CAN

0.00%

52.0¢

CANN GROUP LIMITED

Market Cap $144.4M Add to my watchlist

ASX Cannabis showcase

Medicinal cannabis player Creso Pharma (CPH) is set to acquire Halucenex Life Sciences, a Canadian psychedelics treatment company.Creso has signed an agreement to buy the life sciences developer, which is geared towards researching and developing psychedelic...

Latest Threads

Tag

Subject

CAN

Creso Pharma (ASX:CPH) eyes medicinal psychedelics market

27/03/21

4.1K

27/03/21

Last post KelpieInvestor

4.1K

CAN

Sell! Sell!

19/04/21

22K

19/04/21

Last post DavidHill

22K

CAN

Mildura site is a busy place

16/04/21

6.1K

16/04/21

Last post amb005

6.1K

CAN

Ann: Cann and Emyria investor webinar

15/04/21

3.8K

15/04/21

Last post stultissimus

3.8K

CAN

Ann: EMD: Emyria and Cann Group Investor Webinar

30/03/21

239

30/03/21

Last post

ASX News

239

CAN

Ann: Cann commences proceeding in Hong Kong to recover funds

29/03/21

1.4K

29/03/21

Last post Tsanga

1.4K

CAN

Ann: Cann and Emyria partner to register CBD product

29/03/21

1.6K

29/03/21

Last post kvsae

1.6K

CAN

Ann: EMD: Emyria and Cann Partner to Register CBD Product

29/03/21

274

29/03/21

Last post

ASX News

274

See All Discussions

Timeline

Cann and Emyria investor webinar
30 Mar 15:32	Share

EMD: Emyria and Cann Group Investor Webinar
30 Mar 15:24	Share

Cann commences proceeding in Hong Kong to recover funds
29 Mar 15:09	Share

EMD: Emyria and Cann Partner to Register CBD Product
29 Mar 09:22	Share

Cann and Emyria partner to register CBD product
29 Mar 09:22	Share

Notice under section 708A(5(e) of the Corporations Act
11 Mar 14:12	Share

Cann completes acquisition of Satipharm business
10 Mar 14:37	Share

Appendix 2A - Issue of shares for Satipharm acquisition
10 Mar 14:33	Share

Cann supplies medicinal cannabis for clinical trial
09 Mar 09:00	Share

Cann Group - Half yearly investor presentation
22 Feb 08:56	Share

Cann releases half-year results - 31 December 2020
22 Feb 08:55	Share

Half Yearly Report and Accounts
22 Feb 08:54	Share

HY21 Results - investor webinar
19 Feb 14:59	Share

Notice under s708A(5)(e) - issue of shares
19 Feb 08:49	Share

Appendix 2A - Issue of shares to CSIRO
19 Feb 08:45	Share

Appendix 2A - Exercise of options
19 Feb 08:44	Share

Proposed issue of Securities - CAN
18 Feb 14:07	Share

Replacement Appendix 2A
17 Feb 10:07	Share

Notice under s.708A(5)(e)
17 Feb 10:07	Share

Federal Court orders granted
17 Feb 10:04	Share

Trading Halt
16 Feb 08:59	Share

Cann investor update
15 Feb 08:24	Share

Proposed issue of Securities - CAN
15 Feb 08:23	Share

Cann executes agreement to acquire Satipharm business
15 Feb 08:23	Share

Cann provides revenue update
15 Feb 08:16	Share

Cyber security incident
08 Feb 09:30	Share

Correction of trading halt request
05 Feb 14:08	Share

Trading Halt
05 Feb 10:45	Share

Pause in Trading
05 Feb 10:22	Share

Appendix 4C - quarterly
28 Jan 11:26	Share

View More

(20min delay) Trade with IG
Last 52.0¢		Change 0.000(0.00%)		Mkt cap ! $144.4M

Open	High	Low	Value	Volume
51.5¢	53.0¢	51.5¢	$314.0K	604.3K

Buyers (Bids)

No.	Vol.	Price($)
13	117862	51.5¢

Sellers (Offers)

Price($)	Vol.	No.
52.0¢	64319	3

View Market Depth

No.	Vol.	Price($)
13	117862	0.515
24	165755	0.510
10	236122	0.505
83	690771	0.500
9	104600	0.495

Price($)	Vol.	No.
0.520	64319	3
0.525	27633	3
0.530	55219	5
0.535	15690	4
0.540	51990	7

Last trade - 16.10pm 20/04/2021 (20 minute delay)

(live)
Last 52.0¢		Change 0.000 ( 0.00 %)
Open	High	Low	Volume
52.0¢	53.0¢	51.5¢	206325
Last updated 15.48pm 20/04/2021 (live) ?

CAN (ASX) Chart